Seeing Is Believing
Currently out of the existing stock ratings of David Low, 4 are a HOLD (20%), 14 are a BUY (70%), 2 are a SELL (10%).
Analyst David Low works at JPMORGAN with a stock forecast success ratio of 71.43% fulfilled within 251 days on average.
David Low’s has documented 34 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 10-Jan-2024.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 5/21/2021. The price target of $219 was fulfilled within 24 days with a profit of $21.48 (10.87%) receiving and performance score of 4.53.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
224
$43.65 (24.20%)
215
23 days ago
5/7 (71.43%)
$34.68 (18.32%)
371
Buy
215
$34.65 (19.21%)
215
28 days ago
7/11 (63.64%)
$18.67 (9.51%)
66
Buy
205
$24.65 (13.67%)
185
2 months 25 days ago
5/11 (45.45%)
$14.1 (7.39%)
88
164
$-16.35 (-9.07%)
158
2 months 30 days ago
4/6 (66.67%)
$-21.88 (-11.77%)
30
Buy
207
$26.65 (14.78%)
2 months 30 days ago
4/5 (80%)
$21.12 (11.36%)
60
Which stock is David Low is most bullish on?
What Year was the first public recommendation made by David Low?